USCA RIA’s Invesco Pharmaceuticals ETF PJP Stock Holding History

USCA RIA’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$1.75M	Buy	21,753 +1,366	+7%	+$108K	0.11%	240
2021 Q1	$1.61M	Buy	20,387 +1,236	+6%	+$96.4K	0.11%	241
2020 Q4	$1.37M	Buy	19,151 +1,446	+8%	+$96.8K	0.1%	202
2020 Q3	$1.13M	Buy	+17,705	New	+$1.16M	0.09%	197

Other funds holding PJP

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

USCA RIA's PJP Position: Q2 2021 in Review

USCA RIA increased its Invesco Pharmaceuticals ETF (PJP) stake by 6.7% in Q2 2021, buying an estimated $108K and bringing the position to 21,753 shares worth $1.75M. The position accounts for 0.11% of the portfolio, ranked #240.

USCA RIA first reported a position in PJP in Q3 2020 and has held it in 4 quarters since. 90 funds tracked by Wall St. Rank hold PJP as of Q2 2021.

USCA RIA held 21,753 shares of Invesco Pharmaceuticals ETF worth $1.75M as of Q2 2021.
USCA RIA bought 1,366 Invesco Pharmaceuticals ETF shares in Q2 2021, an estimated $108K.
Invesco Pharmaceuticals ETF made up 0.11% of USCA RIA's portfolio in Q2 2021, its #240 holding.
USCA RIA first reported a position in Invesco Pharmaceuticals ETF in Q3 2020 and has held it in 4 quarters since.
90 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2021.

Based on USCA RIA's 13F filing for Q2 2021, filed 28 Jul 2021.